A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022)
Clinical trial NCT01860729 · COMPLETED
Trial details
- NCT number
- NCT01860729
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-13
- Primary completion
- 2015-05-29
- Enrollment
- 589
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.